Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

The antipsychotic agent quetiapine is increasingly not used as such: dispensed prescriptions in Norway 2004–2015

Gjerden, Pål, Bramness, Jørgen G., Tvete, Ingunn Fride, Slørdal, Lars · 2017 · European Journal of Clinical Pharmacology

Abstract

Purpose The antipsychotic agent quetiapine was introduced in Norway in 2003. We have assessed changes in dispensed prescriptions, including dosing, of quetiapine in Norway from 2004 to 2015.Methods Data on the sales of antipsychotics and antidepressants were drawn from the Norwegian Prescription Database. A total of 47,474 outpatients filled 195,622 prescriptions of quetiapine. Reimbursement codes, use of antipsychotics or antidepressants 12 months prior to the first prescription of quetiapine and estimated mean volume used measured as defined daily doses (DDDs) per day were used as proxies for diagnoses. We conducted a regression analysis with DDD per day as a function of possible explanatory variables.Results The number of users filling at least two prescriptions of quetiapine per year increased from 584 in 2004 to 8506 in 2015 and the mean dose declined from 1.58 DDD per day (SD 8.00) to 0.48 DDD per day (SD 2.27). The latter is much lower than recommended for treatment of psychoses. In 2015, 60.1% of the 8506 quetiapine users did not seek reimbursement for the treatment of a major psychiatric disorder and only 2.6% of the patients were prescribed 1 DDD or more per day and reimbursed in accordance with the drug's primary indication, psychosis. A reported diagnosis of psychosis was not associated with higher quetiapine doses.Conclusions In 2015, the pattern of quetiapine dispensing in Norway most likely reflects predominant off-label use. This is unsettling considering poorly documented effects in non-psychotic disorders, profound side effects, significant toxicity and growing concern regarding abuse.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00228-017-2281-8

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 22 references

Research works printed but not linked: 3

  1. Furu K, Strøm H, Rønning M et al (2005) The Norwegian Prescription Database (NorPD): new register for pharmacoepidemiological research covering a whole nation. Pharmacoepidemiol Drug Saf 14(Suppl. 2):S48
  2. WHO Collaborating Centre for Drug Statistics Methodology (2016) ATC/DDD index 2016. WHO, Oslo
  3. Maglione M, Ruelaz Maher A, Hu J et al (2011) Off-label use of atypical antipsychotics: an update. Comparative effectiveness review no. 43. AHRQ publication no. 11-EHC078-EF. Agency for healthcare research and quality, Rockville

Cited by

See all 48

Metadata

Authors
Gjerden, P., Bramness, J. G., Tvete, I. F., & Slørdal, L.
Affiliations
  • Telemark Hospital (NO)
  • Innlandet Hospital Trust (NO)
  • Norwegian Computing Center (NO)
  • Norwegian University of Science and Technology (NO)
Corresponding author
Gjerden, Pål
Venue
European Journal of Clinical Pharmacology
Published
2017-06-16
Volume
73
Issue
9
Pages
1173-1179
ISSN
  • 0031-6970 (ISSN-L)
  • 1432-1041
OpenAlex
W2625982650
Cited by
48
References
22
Citations by year
2026: 2 · 2025: 5 · 2024: 3 · 2023: 3 · 2022: 5 · 2021: 12 · 2020: 4 · 2019: 5 · 2018: 6 · 2017: 2
FWCI
3.84
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Clinical Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • The Johanne and Einar Eilertsen's research foundation in the memory of their son Johan Eilertsen
  • The Thora and Sverre Lofthus foundation
  • The Institute of Laboratory Medicine, Children's and Women's Health, The Norwegian University of Science and Technology
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords
quetiapine, off-label drug use, antipsychotic prescribing, psychosis, defined daily doses, prescribing patterns, antidepressant use, reimbursement codes, drug abuse, Norway
MeSH terms
Quetiapine Fumarate, Adolescent, Adult, Aged, Antidepressive Agents, Child, Drug Utilization, Female, Humans, Male, Norway, Antipsychotic Agents, Databases, Factual, Young Adult, Off-Label Use

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The antipsychotic agent quetiapine is increasingly not used as such: dispensed prescriptions in Norway 2004–2015. https://app.cochat.ai/papers/10.1007/s00228-017-2281-8
The paper
Gjerden, P., Bramness, J. G., Tvete, I. F., & Slørdal, L. (2017). The antipsychotic agent quetiapine is increasingly not used as such: dispensed prescriptions in Norway 2004–2015. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-017-2281-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.